Intracel Corporation Company Profile

11:30 EDT 22nd September 2017 | BioPortfolio

INTRACEL Corporation is a biopharmaceutical company developing and commercializing cancer vaccines and immunotherapeutic products for cancer and infectious diseases. The company has built a large portfolio of product candidates. Most advanced of which, OncoVAX® , is a vaccine for Stage II colon cancer patients and is currently being marketed and provided on a commercial basis in the Netherlands. Late-Stage product candidates include: KLH (Keyhole Limpet Hemocyanin) for advanced bladder cancer and OncoVAX® for Stage III colon cancer patients, which are both in Phase III development. INTRACEL has a number of fully human monoclonal antibodies in earlier stages of development to treat respiratory syncytial virus (RSV), major hospital infections and autoimmune disorders. The antibodies have emerged from a powerful discovery platform base that combines phage display technology with one of the world’s largest repositories of human antibody responses.

The company plans to commercialize these products through direct investments and corporate partnerships. As part of its business strategy, INTRACEL operates a revenue generating research reagent business.


93 Monocacy Blvd., Unit A-8
United States of America


Phone: (301) 668-8400
Fax: (301) 668-6317

News Articles [69 Associated News Articles listed on BioPortfolio]

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) diso...

Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events

MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...

ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation

RAMSEY, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) announced today that its stockholders voted to approve ADMA’s previously announced acquisition of certain asset...

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease

CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...

International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017

CARLSBAD, Calif., May 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( (“ISCO” or “the Company”), a California-based clinical st...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [173 Associated Companies listed on BioPortfolio]

Intracel Electrophysiology and Biochemistry Equipment

Established in 1986 INTRACEL has become one of the UK's leading suppliers of equipment for researchers in electrophysiology/transgenesis/ICSI and related disciplines. From the earliest days of the com...

Intracel Corporation

INTRACEL Corporation is a biopharmaceutical company developing and commercializing cancer vaccines and immunotherapeutic products for cancer and infectious diseases. The company has built a large por...


Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immu...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Intracel Corporation" on BioPortfolio

We have published hundreds of Intracel Corporation news stories on BioPortfolio along with dozens of Intracel Corporation Clinical Trials and PubMed Articles about Intracel Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intracel Corporation Companies in our database. You can also find out about relevant Intracel Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record